SUBSCRIBE
SUBSCRIBE
News   FDA

Warner Chilcott Gets FDA OK for 150 mg Acne Drug

June 23, 2008 | 
1 min read
Warner Chilcott Ltd. said Monday the Food and Drug Administration approved a 150 mg strength of Doryx delayed-release tablets as a treatment for severe acne.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company.
Obesity
Teva Brings First GLP-1 Generic for Obesity, Targets Novo’s Saxenda
August 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Vaccines
FDA Clears Updated COVID-19 Shots From Pfizer, Moderna, Novavax—But With Restrictions
August 28, 2025
 · 
2 min read
 · 
Tristan Manalac
A pit crew working on a race car
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Creative collage human 3d hands body fragments needle injection gloves medical healthcare hospital virus prevention drawing background.
Vaccines
FDA Pulls Valneva’s Chikungunya Shot From Market Citing ‘Serious Safety Concerns’
August 25, 2025
 · 
2 min read
 · 
Tristan Manalac